Smith Group Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,750	Closed	-$647K	–	180
2024 Q4	$647K	Sell	2,750 -50	-2%	-$11.8K	0.05%	116
2024 Q3	$770K	Buy	+2,800	New	+$770K	0.06%	74
2013 Q3	–	Sell	-69,031	Closed	-$2.14M	–	413
2013 Q2	$2.14M	Buy	+69,031	New	+$2.14M	0.09%	161